18,176 Shares in HCA Healthcare, Inc. $HCA Purchased by Wealthfront Advisers LLC

Key Points

• Wealthfront Advisers purchased 18,176 HCA Healthcare shares in the second quarter, valued at approximately $7.1 million. Institutional investors collectively own 62.73% of the company.
• Analysts maintain a generally positive outlook, with a “Moderate Buy” consensus rating and an average price target of $465.59, though several firms recently lowered their targets.
• HCA reported quarterly revenue of $20.23 billion and adjusted earnings of $7.59 per share, exceeding estimates, while revenue increased 8.7% year over year. The company also declared a quarterly dividend of $0.78 per share, yielding about 0.8%.

Wealthfront Advisers LLC bought a new position in shares of HCA Healthcare, Inc. (NYSE:HCA - Free Report) during the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm bought 18,176 shares of the company's stock, valued at approximately $7,087,000.

Several other hedge funds and other institutional investors have also bought and sold shares of the business. Palisade Asset Management LLC bought a new stake in HCA Healthcare in the 3rd quarter valued at about $26,000. Ares Financial Consulting LLC purchased a new position in HCA Healthcare in the 4th quarter valued at approximately $31,000. Cedar Mountain Advisors LLC bought a new stake in shares of HCA Healthcare during the 1st quarter valued at $33,000. MCF Advisors LLC grew its holdings in HCA Healthcare by 213.0% during the 4th quarter. MCF Advisors LLC now owns 72 shares of the company's stock valued at $34,000 after buying an additional 49 shares in the last quarter. Finally, MidFirst Bank purchased a new stake in shares of HCA Healthcare in the second quarter worth about $28,000. Hedge funds and other institutional investors own 62.73% of the company's stock.

Analyst Upgrades and Downgrades

Several research firms recently commented on HCA. JPMorgan Chase & Co. reduced their target price on HCA Healthcare from $535.00 to $490.00 and set a "neutral" rating for the company in a research report on Tuesday, May 19th. Barclays lowered their target price on shares of HCA Healthcare from $402.00 to $387.00 and set an "equal weight" rating on the stock in a research note on Monday, July 27th. Cantor Fitzgerald decreased their price target on shares of HCA Healthcare from $588.00 to $525.00 and set an "overweight" rating on the stock in a report on Tuesday, July 7th. Sanford C. Bernstein reiterated a "market perform" rating on shares of HCA Healthcare in a research report on Wednesday, July 15th. Finally, Mizuho cut their price objective on HCA Healthcare from $525.00 to $475.00 and set an "outperform" rating for the company in a report on Tuesday, July 28th. Fourteen research analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat, the stock currently has an average rating of "Moderate Buy" and an average price target of $465.59.

HCA Healthcare Stock Down 1.1%

NYSE:HCA opened at $407.28 on Thursday. HCA Healthcare, Inc. has a twelve month low of $353.99 and a twelve month high of $556.52. The firm's fifty day simple moving average is $395.75 and its 200 day simple moving average is $444.82. The stock has a market cap of $88.18 billion, a P/E ratio of 13.64, a price-to-earnings-growth ratio of 1.43 and a beta of 1.10.

HCA Healthcare (NYSE:HCA - Get Free Report) last issued its quarterly earnings results on Friday, July 24th. The company reported $7.59 earnings per share for the quarter, beating the consensus estimate of $7.56 by $0.03. HCA Healthcare had a negative return on equity of 244.79% and a net margin of 8.77%.The firm had revenue of $20.23 billion during the quarter, compared to the consensus estimate of $19.76 billion. During the same period last year, the company earned $6.84 earnings per share. The company's revenue was up 8.7% on a year-over-year basis. On average, analysts expect that HCA Healthcare, Inc. will post 29.47 EPS for the current fiscal year.

HCA Healthcare Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Wednesday, September 30th. Investors of record on Wednesday, September 16th will be issued a $0.78 dividend. This represents a $3.12 annualized dividend and a yield of 0.8%. The ex-dividend date of this dividend is Wednesday, September 16th. HCA Healthcare's dividend payout ratio is currently 10.45%.

HCA Healthcare Company Profile

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company's core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA's services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.

Want to see what other hedge funds are holding HCA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCA Healthcare, Inc. (NYSE:HCA - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source